Abstract
Acupuncture and moxibustion have been accepted as add-on options for primary dysmenorrhea (PD); however, the clinical evidence is still inadequate. We searched AMED, CENTRAL, EMBASE, PubMed, Web of Science, CBM, CNKI, VIP, Wangfang database, ANZCTR, ClinicalTrials.gov, and the WHO ICTRP, from their inception to February 2021. The pooled analysis of 13 RCTs with 675 participants for VAS showed that acupuncture and moxibustion were more effective in managing PD than the control group with the MD of −1.93 (95% CI [−2.80, −1.06] and −2.67 (95% CI [−4.96, −0.38]). With the CMSS, seven studies with 487 participants showed that these modalities were more effective than the control group with the MD of −7.58 (95% CI [−10.97, −4.19]) and −3.78 (95% CI [−6.90, −0.66]). The findings indicated that acupuncture and moxibustion could relieve pain effectively and has fewer adverse events (AEs) in managing PD.
RAS ID
44377
Document Type
Journal Article
Date of Publication
9-2022
Funding Information
Edith Cowan University and Industry Collaboration Scholarship (G1004906)
School
School of Nursing and Midwifery / School of Science
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Publisher
Sage
Comments
Liu, W., Wang, C. C., Lee, K. H., Ma, X., & Kang, T. L. (2022). Efficacy and safety of acupuncture and or moxibustion for managing primary dysmenorrhea: A systematic review and meta-analysis. Clinical Nursing Research, 31(7), 1632-1375.
https://doi.org/10.1177/10547738221086984